• Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer 

  Ali, HR; Dawson, S-J; Blows, FM; Provenzano, E; Pharoah, PD; Caldas, C (NATURE PUBLISHING GROUP, 2012-05-22)

  BACKGROUND: Proliferation has emerged as a major prognostic factor in luminal breast cancer. The immunohistochemical (IHC) proliferation marker Ki67 has been most extensively investigated but has not gained widespread ...

• Characterisation of microbial communities within aggressive prostate cancer tissues 

  Yow, MA; Tabrizi, SN; Severi, G; Bolton, DM; Pedersen, J; Prostate, A; Giles, GG; Southey, MC (BMC, 2017-01-13)

  BACKGROUND: An infectious aetiology for prostate cancer has been conjectured for decades but the evidence gained from questionnaire-based and sero-epidemiological studies is weak and inconsistent, and a causal association ...

• Concordance between actual and pharmacogenetic predicted desvenlafaxine dose needed to achieve remission in major depressive disorder: a 10-week open-label study 

  Bousman, CA; Mueller, DJ; Ng, CH; Byron, K; Berk, M; Singh, AB (LIPPINCOTT WILLIAMS & WILKINS, 2017-01-01)

  BACKGROUND: Pharmacogenetic-based dosing support tools have been developed to personalize antidepressant-prescribing practice. However, the clinical validity of these tools has not been adequately tested, particularly for ...

View more